Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing mammary tumors during a period of time
go back to main search page
Accession:CMO:0000948 term browser browse the term
Definition:The number of individuals in a study population which develop new instances of mammary tumors during a certain period compared to the total number of individuals in the study population, expressed as a percentage. A tumor is an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
Synonyms:related_synonym: mammary tumor incidence



show annotations for term's descendants           Sort by:
 

Related Phenotype Data for Term "percentage of study population developing mammary tumors during a period of time" (CMO:0000948)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    tumor measurement 0
      mammary tumor measurement 0
        mammary tumor incidence/prevalence measurement 0
          percentage of study population developing mammary tumors during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          organ tumorous lesion incidence/prevalence measurement 0
            tumor incidence/prevalence measurement 0
              mammary tumor incidence/prevalence measurement 0
                percentage of study population developing mammary tumors during a period of time 0
paths to the root